In PsA, the phase 3b TOGETHER-PsA trial (NCT06588296) assesses the combined use of ixekizumab and tirzepatide in patients with active disease and concomitant overweight or obesity, while the phase 4 TOGETHER AMPLIFY-PsA study (NCT06864026) examines the effectiveness of adding tirzepatide to ixekizumab in clinical practice over 12 months
Glucagon-like peptide 1 (GLP-1) receptor agonists as a protective factor for incident depression in patients with diabetes mellitus: a systematic review
The combination of better sleep, improved body composition, enhanced recovery, and hormonal optimization creates a compounding effect on subjective quality of life
Risks of Rapid Weight Loss Gallstones Muscle loss Electrolyte imbalance Loose skin Mental burnout GLPs do reduce appetite, but too-fast results can backfire, especially if youre not supporting your body with proper nutrition
Mt s thuc c th k n: Glutathione hin ti cha gy ra cc tng tc vi cc loi thuc khc, c bit l thuc dng trong ha tr
The survival of T315I leukemia mice was not affected by UK-5099 therapy